Unknown

Dataset Information

0

Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.


ABSTRACT: BACKGROUND:Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors that are mostly benign. Metastatic disease does occur in about 10% of cases of PCC and up to 25% of PGL, and for these patients no effective therapies are available. Patients with mutations in the succinate dehydrogenase subunit B (SDHB) gene tend to have metastatic disease. We hypothesized that a down-regulation in the active succinate dehydrogenase B subunit should result in notable changes in cellular metabolic profile and could present a vulnerability point for successful pharmacological targeting. METHODS:Metabolomic analysis was performed on human hPheo1 cells and shRNA SDHB knockdown hPheo1 (hPheo1 SDHB KD) cells. Additional analysis of 115 human fresh frozen samples was conducted. In vitro studies using N1,N11-diethylnorspermine (DENSPM) and N1,N12- diethylspermine (DESPM) treatments were carried out. DENSPM efficacy was assessed in human cell line derived mouse xenografts. RESULTS:Components of the polyamine pathway were elevated in hPheo1 SDHB KD cells compared to wild-type cells. A similar observation was noted in SDHx PCC/PGLs tissues compared to their non-mutated counterparts. Specifically, spermidine, and spermine were significantly elevated in SDHx-mutated PCC/PGLs, with a similar trend in hPheo1 SDHB KD cells. Polyamine pathway inhibitors DENSPM and DESPM effectively inhibited growth of hPheo1 cells in vitro as well in mouse xenografts. CONCLUSIONS:This study demonstrates overactive polyamine pathway in PCC/PGL with SDHB mutations. Treatment with polyamine pathway inhibitors significantly inhibited hPheo1 cell growth and led to growth suppression in xenograft mice treated with DENSPM. These studies strongly implicate the polyamine pathway in PCC/PGL pathophysiology and provide new foundation for exploring the role for polyamine analogue inhibitors in treating metastatic PCC/PGL. PRéCIS: Cell line metabolomics on hPheo1 cells and PCC/PGL tumor tissue indicate that the polyamine pathway is activated. Polyamine inhibitors in vitro and in vivo demonstrate that polyamine inhibitors are promising for malignant PCC/PGL treatment. However, further research is warranted.

SUBMITTER: Rai SK 

PROVIDER: S-EPMC7482423 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.

Rai Sudhir Kumar SK   Bril Fernando F   Hatch Heather M HM   Xu Yiling Y   Shelton Laura L   Kalavalapalli Srilaxmi S   Click Arielle A   Lee Douglas D   Beecher Chris C   Kirby Austin A   Kong Kimi K   Trevino Jose J   Jha Abhishek A   Jatav Shashank S   Kriti Kriti K   Luthra Soumya S   Garrett Timothy J TJ   Guingab-Cagmat Joy J   Plant Daniel D   Bose Prodip P   Cusi Kenneth K   Hromas Robert A RA   Tischler Arthur S AS   Powers James F JF   Gupta Priyanka P   Bibb James J   Beuschlein Felix F   Robledo Mercedes M   Calsina Bruna B   Timmers Henri H   Taieb David D   Kroiss Matthias M   Richter Susan S   Langton Katharina K   Eisenhofer Graeme G   Bergeron Raymond R   Pacak Karel K   Tevosian Sergei G SG   Ghayee Hans K HK  

Metabolism: clinical and experimental 20200618


<h4>Background</h4>Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors that are mostly benign. Metastatic disease does occur in about 10% of cases of PCC and up to 25% of PGL, and for these patients no effective therapies are available. Patients with mutations in the succinate dehydrogenase subunit B (SDHB) gene tend to have metastatic disease. We hypothesized that a down-regulation in the active succinate dehydrogenase B subunit should result in notable changes in cellu  ...[more]

Similar Datasets

| S-EPMC7072390 | biostudies-literature
| S-EPMC6627450 | biostudies-literature
| S-EPMC7795591 | biostudies-literature
| S-EPMC7443979 | biostudies-literature
| S-EPMC6520899 | biostudies-literature
| S-EPMC8905338 | biostudies-literature
| S-EPMC9923802 | biostudies-literature
| S-EPMC10073672 | biostudies-literature
| S-EPMC7051940 | biostudies-literature
| S-EPMC8882896 | biostudies-literature